Literature DB >> 24460487

Radiosurgery for Spetzler-Martin Grade III arteriovenous malformations.

Dale Ding1, Chun-Po Yen, Robert M Starke, Zhiyuan Xu, Xingwen Sun, Jason P Sheehan.   

Abstract

OBJECT: Intracranial arteriovenous malformations (AVMs) are most commonly classified based on their Spetzler-Martin grades. Due to the composition of the Spetzler-Martin grading scale, Grade III AVMs are the most heterogeneous, comprising 4 distinct lesion subtypes. The management of this class of AVMs and the optimal treatment approach when intervention is indicated remain controversial. The authors report their experience with radiosurgery for the treatment of Grade III AVMs in a large cohort of patients.
METHODS: All patients with Spetzler-Martin Grade III AVMs treated with radiosurgery at the University of Virginia over the 20-year span from 1989 to 2009 were identified. Patients who had less than 2 years of radiological follow-up and did not have evidence of complete obliteration during that period were excluded from the study, leaving 398 cases for analysis. The median patient age at treatment was 31 years. The most common presenting symptoms were hemorrhage (59%), seizure (20%), and headache (10%). The median AVM volume was 2.8 cm(3), and the median prescription dose was 20 Gy. The median radiological and clinical follow-up intervals were 54 and 68 months, respectively. Univariate and multivariate Cox proportional hazards and logistic regression analysis were used to identify factors associated with obliteration, postradiosurgery radiation-induced changes (RIC), and favorable outcome.
RESULTS: Complete AVM obliteration was observed in 69% of Grade III AVM cases at a median time of 46 months after radiosurgery. The actuarial obliteration rates at 3 and 5 years were 38% and 60%, respectively. The obliteration rate was higher in ruptured AVMs than in unruptured ones (p < 0.001). Additionally, the obliteration rate for Grade III AVMs with small size (< 3 cm diameter), deep venous drainage, and location in eloquent cortex was higher than for the other subtypes (p < 0.001). Preradiosurgery AVM rupture (p = 0.016), no preradiosurgery embolization (p = 0.003), increased prescription dose (p < 0.001), fewer isocenters (p = 0.006), and a single draining vein (p = 0.018) were independent predictors of obliteration. The annual risk of postradiosurgery hemorrhage during the latency period was 1.7%. Two patients (0.5%) died of hemorrhage during the radiosurgical latency period. The rates of symptomatic and permanent RIC were 12% and 4%, respectively. Absence of preradiosurgery AVM rupture (p < 0.001) and presence of a single draining vein (p < 0.001) were independent predictors of RIC. Favorable outcome was observed in 63% of patients. Independent predictors of favorable outcome were no preradiosurgery hemorrhage (p = 0.014), increased prescription dose (p < 0.001), fewer isocenters (p = 0.014), deep location (p = 0.014), single draining vein (p = 0.001), and lower Virginia radiosurgery AVM scale score (p = 0.016).
CONCLUSIONS: Radiosurgery for Spetzler-Martin Grade III AVMs yields relatively high rates of obliteration with a low rate of adverse procedural events. Small and ruptured lesions are more likely to become obliterated after radiosurgery than large and unruptured ones.

Entities:  

Mesh:

Year:  2014        PMID: 24460487     DOI: 10.3171/2013.12.JNS131041

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  Predicting outcomes from radiosurgery for intracranial arteriovenous malformations: effect of embolization, prior hemorrhage, and nidus anatomy.

Authors:  Dale Ding
Journal:  Neurol Sci       Date:  2014-12-02       Impact factor: 3.307

2.  Surgical Approaches for Symptomatic Cerebral Cavernous Malformations of the Thalamus and Brainstem.

Authors:  Dale Ding; Robert M Starke; R Webster Crowley; Kenneth C Liu
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2017-03-31

Review 3.  Modern radiosurgical and endovascular classification schemes for brain arteriovenous malformations.

Authors:  Ali Tayebi Meybodi; Michael T Lawton
Journal:  Neurosurg Rev       Date:  2018-05-04       Impact factor: 3.042

Review 4.  Complete seizure-free rates following interventional treatment of intracranial arteriovenous malformations: a systematic review and meta-analysis.

Authors:  James C Mamaril-Davis; Pedro Aguilar-Salinas; Mauricio J Avila; Peter Nakaji; Robert W Bina
Journal:  Neurosurg Rev       Date:  2022-01-06       Impact factor: 3.042

Review 5.  Medical vs. invasive therapy in AVM-related epilepsy: Systematic review and meta-analysis.

Authors:  Colin B Josephson; Khara Sauro; Samuel Wiebe; Fiona Clement; Nathalie Jette
Journal:  Neurology       Date:  2015-12-07       Impact factor: 9.910

6.  Diagnosis and evaluation of intracranial arteriovenous malformations.

Authors:  Andrew Conger; Charles Kulwin; Michael T Lawton; Aaron A Cohen-Gadol
Journal:  Surg Neurol Int       Date:  2015-05-12

7.  Using a Machine Learning Approach to Predict Outcomes after Radiosurgery for Cerebral Arteriovenous Malformations.

Authors:  Eric Karl Oermann; Alex Rubinsteyn; Dale Ding; Justin Mascitelli; Robert M Starke; Joshua B Bederson; Hideyuki Kano; L Dade Lunsford; Jason P Sheehan; Jeffrey Hammerbacher; Douglas Kondziolka
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

8.  Preoperative Embolization of Cerebral Arteriovenous Malformations with Silk Suture and Particles: Technical Considerations and Outcomes.

Authors:  Jordan R Conger; Dale Ding; Daniel M Raper; Robert M Starke; Christopher R Durst; Kenneth C Liu; Mary E Jensen; Avery J Evans
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2016-06-30

Review 9.  Multimodal Treatment Strategy for Spetzler-Martin Grade III Arteriovenous Malformations of the Brain.

Authors:  Bikei Ryu; Tatsuya Ishikawa; Takakazu Kawamata
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-05-11       Impact factor: 1.742

10.  Stereotactic radiosurgery for thalamus arteriovenous malformations.

Authors:  Mohameth Faye; Moussa Diallo; Manal Sghiouar; Elhadji Cheikh Ndiaye Sy; Pierre Yves Borius; Jean-Marie Régis
Journal:  J Radiosurg SBRT       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.